From Orthopedic to Internal Medicine: Practical Applications of Regenerative Therapies
1.0 CE Credit Hour / Jamie Gaynor, DVM, MS, DACVAA, DAIPM; Robert Harman, DVM, MPVM
JAMIE GAYNOR, Medical Director, DVM, MS, DACVAA, DAIPM
Dr. Gaynor completed his undergraduate degree from The Colorado College in 1983 and received his veterinary degree (DVM) from The Ohio State University in 1988. He was in private small animal practice in northeastern Ohio for 1 year prior to returning to The Ohio State University for a 3 year residency in Anesthesiology. He is currently board certified in veterinary anesthesiology and a Certified Veterinary Pain Practitioner. He is also certified in veterinary acupuncture and is a Diplomate of the American Academy of Pain Management. Dr. Gaynor joined the faculty at Colorado State University in 1992 and was Section chief and associate professor of anesthesiology and pain management when he left the University in 2004. He is a past member of both the Leadership Council for the Companion Animal Pain Management Consortium and the International Veterinary Academy of Pain Management. Dr. Gaynor enjoys spending time with his family and 4 dogs. When not working, he can frequently be found bicycling on the road or trails, hiking or skiing.
Robert Harman, DVM, MPVM
Dr. Bob Harman received his Doctor of Veterinary Medicine and Master’s in Epidemiology from the University of California, Davis. His career path from that point has been anything but ordinary. He started out in Bovine Medicine, with a dairy practice combined with conducting clinical trials for the veterinary pharma industry (dogs, cats, horses, cows, etc). This formalized into HTI Bio-Services, a contract company for veterinary product development including FDA studies. The human biotech industry found Dr. Harman and HTI convinced him to add in human preclinical studies to the menu. Over a decade of service, his team developed the first cardiac stent (J&J), the first cell therapy product for human burn wound therapy, along with hundreds of other amazing vet and human therapies! He has authored more than 500 contract study reports for animal health companies throughout the world and for submission to the FDA and USDA in support of the development of new animal and human health products. After the successful sale of HTI-Bio Sciences, Dr Harman decided to retire and pursue his passion for playing Polo. Retirement didn’t last very long, and after attending a stem cell lecture where he saw the ability of stem cells to turn into beating heart tissue in a petri dish, he decided to jump back into industry. Dr Harman started the first US-based commercial veterinary Stem Cell company VetStem Inc. In the past 20 years as CEO and Chief Scientific Officer at VetStem he has seen the use of Regenerative Medicine in the veterinary field grow in exciting ways. His passion for Regenerative Medicine and what it can offer both animals and humans is evident whenever he speaks on the topic. Translational medicine was introduced to Dr. Harman as a UC Davis student in 1980 by Dr. Calvin Schwabe, the man who coined the term One Medicine in the modern era. In keeping with this passion, he co-founded Personalized Stem Cells, Inc., a human stem cell company founded and built on the 20 years of clinical regenerative veterinary medicine that has spanned 40 diseases, 61 species and treatments for over 25,000 veterinary patients. Give him a holler about getting those knees and backs treated!
Program Description:
Join us for an enlightening session designed for veterinarians interested in the expanding role of regenerative therapies across various medical disciplines. This talk will focus on the practical applications of regenerative medicine, moving beyond traditional orthopedic uses to explore its benefits in internal medicine.
We will discuss key regenerative techniques, including stem cell therapy, platelet-rich plasma (PRP), and other innovative treatments, highlighting their effectiveness in managing a range of conditions such as osteoarthritis, kidney disease, IBD, wound healing and soft tissue injuries. Participants will learn how to integrate these therapies into their practice, enhance patient outcomes, and tailor treatment plans to meet the unique needs of individual animals.
Through case studies and real-world examples, we will illustrate the successful implementation of regenerative therapies in both orthopedic and internal medicine settings. Attendees will leave with actionable insights, practical tips for clinical application, and a deeper understanding of how regenerative medicine can transform patient care across disciplines.
Learning Objectives
- Understand the fundamental principles and techniques of regenerative medicine, including stem cell therapy, platelet-rich plasma (PRP).
- Explore the expanding applications of regenerative therapies beyond orthopedics, with a focus on their role in internal medicine, including kidney disease, IBD, and soft tissue injuries.
- Identify the clinical benefits of regenerative therapies in managing various conditions, such as osteoarthritis, chronic kidney disease, inflammatory bowel disease (IBD), and wound healing.
- Learn how to integrate regenerative therapies into a veterinary practice, including patient selection, treatment protocols, and expected outcomes.
- Examine case studies and real-world examples to understand the practical applications and success stories of regenerative treatments in both orthopedic and internal medicine settings.
This course is RACE-approved for 1.0 continuing education credits hours in jurisdictions that accept RACE-approval.